(Q40392702)

English

Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

3

object named as

Gabor Halmos

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

object named as

Gunhild Keller

1 reference

Europe PubMed Central

PubMed publication ID

4 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

author name string

Ben Baker

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Attila Nagy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1312-1321

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16047355%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Mechanisms of antineoplastic action of somatostatin analogs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted approaches to cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

UICC/CRC conference on targeted cancer therapy. Royal Free Hospital School of Medicine, London, December 17-19, 1991

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of targeted treatments in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody drug immunoconjugates for targeted treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypothalamic hormones and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of somatostatin receptors in peritumoral veins of human tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent expression of immunoreactive somatostatin receptors in cervical and endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrinsic Overexpression of Two Different Mechanisms of Resistance to Chemotherapy (P-Glycoprotein and GST-π) in Human Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate ofMDR-1 and heterogeneous pattern ofMRP expression without gene amplification in endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of multidrug resistance-associated protein in endometrial carcinomas: correlation with clinicopathology and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishment of a cell line of human endometrial adenocarcinoma in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21327

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40392702&oldid=2119230629"